Drugs & Targets European Commission approves dosing schedules for Opdivo in melanoma October 25, 2019Vol.45 No.40
Drugs & Targets FDA approves Fast Track designation for bemcentinib in AML indication October 25, 2019Vol.45 No.40
Drugs & Targets Abernethy, Shuren, issue statement on FDA breast implant labelling guidance October 25, 2019Vol.45 No.40
Drugs & Targets FDA grants first-ever modified risk orders to eight smokeless tobacco products October 25, 2019Vol.45 No.40
Drugs & TargetsFree Xenikos receives Fast Track designation for T-Guard for steroid-refractory SR-aGVHD October 18, 2019Vol.45 No.39
Drugs & TargetsFree Flatiron announces clinical decision support application through Epic’s App Orchard October 18, 2019Vol.45 No.39
Drugs & Targets FDA publishes guidance on submission process for determining risk of investigational in vitro diagnostics October 11, 2019Vol.45 No.38
Drugs & TargetsFree FDA approves Janssen’s Darzalex for new multiple myeloma indication September 27, 2019Vol.45 No.36
Drugs & TargetsFree Cologuard gets FDA approval for use in younger patients indication September 27, 2019Vol.45 No.36
